Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade
about
Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implicationsPsychotropic medication characteristics for special education students with emotional and/or behavioral disordersAntipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.Obesity Prevention for Children with Developmental Disabilities.Pediatric Bipolar Disorder: Subtype Trend and Impact of Behavioral Comorbidities.Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.Trends in Atypical Antipsychotics Prescribed to Children Six Years of Age or Less on Medicaid in KentuckyShooting the Messenger: The Case of ADHD.Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services.Patterns of Antipsychotic Prescribing by Physicians to Young Children.Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens.Patterns of Child Mental Health Service Delivery in a Public System: Rural Children and the Role of Rural Residence.Impact of Coordinated Behavioral Health Management on Quality Measures of Antipsychotic Use.“Mental Health” Power and Its Effects: A Commentary on Battling Against Inter-Faith Relations in Israel.Psychotropic drug use among preschool children in the Medicaid program from 36 states.
P2860
Q28295134-EEC9A8C4-21C8-43E8-B188-7D91B248CC1DQ34063651-C5162D3B-2ADE-4875-85EF-6AAD034ABEAEQ34194447-36955ABD-3077-4D48-A6E7-4BFAE0C703ECQ34711543-A23A5E37-1C44-42D5-B841-ADA3F603052AQ35667230-71CFEA27-62EC-4D54-9C84-5997803B602BQ35762240-28859438-00C4-4D35-A621-43452E23DDCFQ36730256-6784B980-A060-4F53-8995-EAF4FA39CDC5Q37568887-75680D61-D78F-4B9F-ACAF-0A34D0673C50Q38905891-A07109C1-B7FF-49DB-A3FF-A617170ECCDAQ39600765-5BC41F12-2A0C-439A-8B45-8DE71A83B6FDQ40386583-7A7BF3EB-4C52-488A-8DCB-AA89F7279319Q41152640-F9C9F75E-3087-4596-8F59-EE8B6B4AB3B8Q47702575-BB591529-5316-4450-BA32-EC3597CCEB98Q48016952-C02EF623-7DC1-4747-BD44-DED3E4A34170Q53239844-789D4163-217B-417E-99BE-FA4E98036C20
P2860
Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@ast
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@en
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@nl
type
label
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@ast
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@en
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@nl
prefLabel
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@ast
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@en
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@nl
P2093
P1433
P1476
Antipsychotic use by medicaid- ...... tric diagnosis across a decade
@en
P2093
Aloysius Ibe
Daniel J Safer
Julie Magno Zito
Laurence S Magder
Mehmet Burcu
P356
10.1176/APPI.PS.201200081
P407
P577
2013-03-01T00:00:00Z